Hemagen Diagnostics, Inc. (HMGN)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Feb 25, 2026
Hemagen Diagnostics Market Cap
Hemagen Diagnostics has a market cap or net worth of $3.10 thousand as of March 9, 2026. Its market cap has decreased by -97.50% in one year.
Market Cap
3.10K
Enterprise Value
n/a
Revenue
4.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 23, 1996, Hemagen Diagnostics's market cap has decreased from 20.30M to 3.10K, a decrease of -99.98%. That is a compound annual growth rate of -25.55%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Comera Life Sciences Holdings | 3.07K |
| Innoveren Scientific | 3.20K |
| Rebus Holdings | 3.21K |
| MetaStat | 3.53K |
| Synovics Pharmaceuticals | 3.65K |
| Anthera Pharmaceuticals | 2.62K |
| Xeno Transplants | 4.04K |
| OncoVista Innovative Therapies | 2.36K |